Ancai Hi-Tech announced that the company plans to sell float glass, medicinal glass and other non-core business assets to the controlling shareholder Henan Investment Group or its designated third party. The targets include the shares of six subsidiaries, related claims, and physical assets of the borosilicate pharmaceutical glass project. The company has signed an agreement of intent with Henan Investment Group. This transaction is expected to constitute a related transaction and not a major asset restructuring. Currently, the specific transaction plan still needs to be further verified and negotiated, and necessary decisions and state-owned assets approval procedures must be carried out. There is still uncertainty about the transaction, and the impact on current results cannot be predicted.

Ancai Hi-Tech announced that the company plans to sell float glass, medicinal glass and other non-core business assets to the controlling shareholder Henan Investment Group or its designated third party. The targets include the shares of six subsidiaries, related claims, and physical assets of the borosilicate pharmaceutical glass project. The company has signed an agreement of intent with Henan Investment Group. This transaction is expected to constitute a related transaction and not a major asset restructuring. Currently, the specific transaction plan still needs to be further verified and negotiated, and necessary decisions and state-owned assets approval procedures must be carried out. There is still uncertainty about the transaction, and the impact on current results cannot be predicted.